Login to Your Account



Eye-itch enrichment: NDA by Nicox for AC might win priority status via kid data

By Randy Osborne
Staff Writer

Tuesday, April 19, 2016

CEO Michele Garufi told BioWorld Today that Nicox SA's eye-drop form of cetirizine "has a good chance to take a nice market share" in eye itching related to allergic conjunctivitis, and could win priority review, thanks to data in pediatric patients.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription